(Q39633896)

English

The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients

scientific article published on April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Zouari Bouassida K

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Chouchane L

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jellouli K

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Chérif S

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Haddad S

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gabbouj S

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Danguir J

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Diabetes and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

119-123

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Guilt by association

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1262-3636(07)70177-5

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39633896&oldid=1848657301"